P548 URINARY TRANSFORMING GROWTH FACTOR-ALPHA AS A TUMOR MARKER FOR HEPATOCELLULAR CARCINOMA
β Scribed by Tsai, J.-F.; Lin, Z.-Y.; Chen, S.-C.; Chuang, W.-L.; Wang, L.-Y.; Yu, M.-L.; Dai, C.-Y.
- Book ID
- 122170960
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 59 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Although alphaβfetoprotein (AFP) is a useful serologic marker of hepatocellular carcinoma (HCC), it has been reported insufficiently sensitive in detecting small HCCs. Plasma transforming growth factorβΞ²1 (TGFΞ²1) has been reported to be elevated in HCC patients compared w
Transforming growth factor u (TGFn) is alleged to play a role in malignant progression as well as normal cell growth in an autocrine manner and its serum levels have been reported to increase during this progression. Most hepatocellular carcinomas (HCC) develop in cirrhotic livers in which hepatocyt
T he report by Shim et al. 1 in this issue of Cancer presents interesting data regarding the potential use of serum transforming growth factor (TGF)-β€1 levels as a tumor marker in patients with colorectal carcinoma. Their findings suggest that TGF-β€ may be helpful in predicting extent of disease and
## Abstract The objective of this study was to determine whether transforming growth factor alpha (TGF alpha) levels could be used as nonspecific tumor markers in patients with advanced squamous cell carcinoma (SCC) of the head and neck. Fourteen patients with epidermoid carcinoma of the head and n